References
- Handbook of Hypertension, Vol 5: Clinical Pharmacology of Antihypertensive Drugs, A. E. Doyle. Elsevier Science Publishers, Amsterdam 1984; 390
- Guazzi M. D., Polese A., Fiorentini C., Bartorelli A., Moruzzi P. Treatment of hypertension with calcium antagonists. Hypertension. 1983; 5: 85, Supplement II
- Halperin A. K., Gross K. M., Rogers J. F., Cubeddu L. X. Verapamil and propranolol in essential hypertension. Clin Pharmacol Ther. 1984; 36: 750–758
- Hornung R. S., Jones R. I., Gould B. A., Sonecha T., Raftery E. B. Propranolol versus verapamil for the treatment of essential hypertension. Am Heart J. 1984; 108: 554–560
- Hypertension Detection and Follow-up Programme Co-operative Group. Five Year Findings of the Hypertension Detection and Follow-up Program. I. Reduction in Mortality of Persons with High Blood Pressure, including Mild Hypertension. II Mortality by Race, Sex and Age. J. A. M. A. 1979; 242: 2562
- Koch-Weser J. Vasodilator drugs in the treatment of hypertension. Arch Int Med. 1974; 133: 1017
- Lewis G. R. J., Morley K. D., Maslowski A. H., Bones P. J. Verapamil in the management of hypertensive patients. Aust NZ J Med. 1979; 9: 62
- Losse H., Zumkley H., Quante T. Side effects of diuretics. Clin Exp Hyperten. 1983; 2: 309
- Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980; 47: 1–9